Drug profile · INN
tepotinib hydrochloride hydrate
TEPMETKO
tepotinib hydrochloride hydrate (TEPMETKO) is a hepatocyte growth factor receptor inhibitor.
PMDA: approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — tepotinib hydrochloride hydrate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.78
Quick answer
tepotinib hydrochloride hydrate (TEPMETKO) is a hepatocyte growth factor receptor inhibitor.
Key facts
INN tepotinib hydrochloride hydrate
Brand TEPMETKO
Mechanism Hepatocyte growth factor receptor inhibitor
Target Hepatocyte growth factor receptor
Mechanism of action
Hepatocyte growth factor receptor inhibitor
Primary target: Hepatocyte growth factor receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is tepotinib hydrochloride hydrate?
tepotinib hydrochloride hydrate (TEPMETKO) is a hepatocyte growth factor receptor inhibitor.
What is the brand name for tepotinib hydrochloride hydrate?
TEPMETKO is a marketed brand name for tepotinib hydrochloride hydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.